Cite
HARVARD Citation
Gantner, P. et al. (n.d.). Efficacy and safety of switching to raltegravir plus atazanavir dual therapy in pretreated HIV-1-infected patients over 144 weeks: a cohort study. Scandinavian journal of infectious diseases. pp. 838-845. [Online].